Plasma exchange therapy is effective for severe relapses in MS patients who respond inadequately to standard corticosteroids, ...

A sublingual formulation of cladribine showed comparable pharmacological properties to its name brand counterpart, Mavenclad.

Anti-CD20 therapies like Ocrevus and rituximab may be ineffective at slowing disability progression in PPMS patients, per a ...

I drive a wheelchair now. Mine tilts and reclines, so it’s a bit heavier than most. It’s not a car, but there’s a certain amount of responsibility that goes with it because like any vehicle, it too is ...

Cionic is partnering with a veteran-owned business to improve access to its Neural Sleeve for improving patients' walking ...

Columnist Leigh Anne Nelson followed the most current information about MS and COVID-19 and flu vaccines when deciding to get ...

Columnist Desiree Lama's MS symptoms have almost always been invisible, which can prompt judgment and questioning from others ...

Acupuncture may be able to help ease fatigue in multiple sclerosis, but more well-designed studies are needed to establish ...

The MS Society of Canada is hosting MS Read-a-Thon to encourage reading and help support people with multiple sclerosis in ...

Poltreg will receive a patent in China to cover the administration of PTG-007 for MS via an intrathecal, or ...

Columnist Desiree Lama has accepted her MS diagnosis as part of her identity — but it's not the only thing that defines her, ...

Confirmed six-month disability progression rates over 4 years were similar in patients given the oral statin or a placebo in ...